Chemed reported third quarter 2026 net income of US$71.65 million versus US$64.24 million a year earlier, with diluted EPS from continuing operations at US$5.45 compared with US$4.46. Across the first...
Source LinkChemed reported third quarter 2026 net income of US$71.65 million versus US$64.24 million a year earlier, with diluted EPS from continuing operations at US$5.45 compared with US$4.46. Across the first...
Source Link
Comments